| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |